The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
2021 · Acta Pharmaceutica Sinica B · 296 citations
https://doi.org/10.1016/j.apsb.2021.05.011
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
4.5K
Citations
24
h-index
27
i10-index
Xianxian Zheng is an academic researcher from Hefei First People's Hospital. The author has contributed to research in topics: Cancer-related Molecular Pathways & Pharmacogenetics and Drug Metabolism & Drug Transport and Resistance Mechanisms. The author has an h-index of 24, co-authored 36 publications.
https://doi.org/10.1016/j.apsb.2021.05.011
https://doi.org/10.1038/bcj.2015.80
Click to start Chat